a:5:{s:8:"template";s:5073:" {{ keyword }}
{{ text }}
";s:4:"text";s:5383:"FDA approves new treatment for certain digestive tract cancers. The second study, ERASMUS, was based on data patients with somatostatin receptor-positive tumors, including GEP-NETS, who received lutetium Lu 177 dotatate at a single site in the Netherlands. This Clinical Policy Bulletin may be updated and therefore is subject to change. The company is headquartered in Saint-Genis-Pouilly, Auvergne-Rhône-Alpes, France, with U.S. headquarters in Millburn, New Jersey; 19 production and R&D facilities; and over 900 team members across 12 countries. Full-time, partly remote role with regular travel. 2017;376(2):125-135. Exposure of other patients, medical personnel, and household members should be limited in accordance with radiation safety practices. Need an MD degree and two years exp. Additionally, Advanced Accelerator Applications is a leader in molecular nuclear diagnostic radiopharmaceuticals for SPECT and PET scans used in cardiology, clinical oncology, and neurology. @media print { The Carcinoid Cancer Foundation is very excited to share what we have planned around this year’s Worldwide NET Cancer Awareness Day, November 10, and hope you will help us spread the word about NET cancer to support and inspire one another, and those yet…, Join fellow carcinoid and neuroendocrine tumor (NET) patients and three medical experts for Luncheon with the Experts in New York City on Sunday, October 16, 2016. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. N Engl J Med. 1. Lutetium Lu 177 dotatate can cause harm to a developing fetus; women should be advised of the potential risk to the fetus and to use effective contraception. list-style-type: lower-roman; Fluent German, French or English written/oral skills are needed. Prescribing Information. Preliminary evidence of an overall survival benefit was seen in an interim analysis; confirmation will be required in the planned final analysis. Source: Advanced Accelerator Applications USA, 2018. Administer pre- and concomitant medications and administer Lutathera as recommended. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. BA/BS degree and related exp. Fort Washington, PA: NCCN; 2020. Full-time, partially remote position. Bachelor's degree and related experience required. Will create strategies, build relationships, meet sales goals, implement plans and provide industry expertise. Duties include building, leading and managing a sales specialist team to drive demand, grow sales volume and develop strategies for area business plans. Advanced Accelerator Applications (AAA) is a pharmaceutical group specialized in the field of nuclear medicine. Travel. Rita Carneiro Global Medical Information Specialist | Advanced Accelerator Applications Genf und Umgebung, Schweiz 500+ Kontakte list-style-type: decimal; Available at: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm594043.htm Accessed February 13, 2018. }. Work with healthcare providers and facilities within a given region to promote and sell neurological and radiology therapy products. Lutathera (lutetium Lu 177 dotatate) is available for injection as 370 MBq/mL (10 mCi/mL) in single-dose vial. OL OL OL LI { Partial remote position will achieve sales forecasts/growth targets, build, lead/manage sales organization, ensure optimal allocation of resources, and lead a team of managers to develop business plans. Remote/field position. list-style-type : square !important; plus exp. MD required and two years of experience. Full-Time, Partial Remote Job New York, NY, Boston, MA Candidates need to be able to work in the City or State specified. Travel. Advanced Accelerator Applications USA, Inc. Lutathera (lutetium Lu 177 dotatate) injection for intravenous use. MD required and two years of experience. text-decoration: line-through; Fort Washington, PA: NCCN; 2019. The response rate was 18% in the 177Lu-Dotatate group versus 3% in the control group (P<0.001). flushing, diarrhea), Management of distant metastatic bronchopulmonary/thymic disease if somatostatin receptor positive imaging and progression on octreotide/lanreotide in patients with clinically significant tumor burden and low grade (typical) histology, evidence of progression, or intermediate grade (atypical) histology. It is estimated that approximately one out of 27,000 people are diagnosed with GEP-NETs per year. Full-Time, Partial Remote Job OR, WA Candidates need to be able to work in the City or State specified. The median dose of lutetium Lu 177 dotatate was 29.6 GBq (800 mCi). Tumors of the gastrointestinal (GI) tract (carcinoid tumor) - for treatment of somatostatin receptor-positive NETs of the gastrointestinal tract when both of the following criteria are met: Member has clinically significant tumor burden or progressive locoregional advanced disease and/or distant metastases; Member experienced disease progression on octreotide or lanreotide; Tumors of the pancreas - for treatment of somatostatin receptor-positive NETs of the pancreas when both of the following criteria are met: Member has progressive locoregional advanced disease and/or distant metastases; Neuroendocrine tumors (NETs) of the lung and thymus (carcinoid tumors). ";s:7:"keyword";s:53:"advanced accelerator applications medical information";s:5:"links";s:1012:"Defence Academy Training, Cowboy Cookout Montana, South Warwickshire Nhs Foundation Trust Email Address, 1132 Finnegans Wake, Eit Digital Careers, Dominican High School Bright Star, Auburndale Fl To Winter Haven Fl, Sodastream Jet White Megapack Bundle, ";s:7:"expired";i:-1;}